Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Seres Therapeutics (MCRB) Receivables - Other (2016 - 2025)

Seres Therapeutics' Receivables - Other history spans 8 years, with the latest figure at $53000.0 for Q3 2025.

  • For Q3 2025, Receivables - Other changed N/A year-over-year to $53000.0; the TTM value through Sep 2025 reached $53000.0, changed N/A, while the annual FY2024 figure was $2.7 million, N/A changed from the prior year.
  • Receivables - Other for Q3 2025 was $53000.0 at Seres Therapeutics, down from $279000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $125.0 million in Q1 2023 and bottomed at $53000.0 in Q3 2025.
  • The 3-year median for Receivables - Other is $5.1 million (2023), against an average of $21.6 million.
  • The largest annual shift saw Receivables - Other skyrocketed 146.08% in 2024 before it crashed 98.5% in 2025.
  • A 3-year view of Receivables - Other shows it stood at $16.9 million in 2023, then plummeted by 84.08% to $2.7 million in 2024, then tumbled by 98.02% to $53000.0 in 2025.
  • Per Business Quant, the three most recent readings for MCRB's Receivables - Other are $53000.0 (Q3 2025), $279000.0 (Q2 2025), and $1.6 million (Q1 2025).